Protective effects of hydrogen-rich saline in uncontrolled hemorrhagic shock.
Zunmin DU, Haipeng Jia, Jing Liu, Xiaomin Zhao, Yun Wang, Xuejun Sun · Experimental and therapeutic medicine · 2014
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In rats, at 30 and 90 min, no significant difference among the experimental groups in the MAP or HR was observed, suggesting that the hydrogen-rich water had no marked influence on the resuscitation of the blood pressure and HR, regardless of whether it was injected IV or IP. These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how hydrogen-rich water affected the outcomes measured in rats. At 30 and 90 min, no significant difference among the experimental groups in the MAP or HR was observed, suggesting that the hydrogen-rich water had no marked influence on the resuscitation of the blood pressure and HR, regardless of whether it was injected IV or IP.
What the Researchers Studied
The researchers studied rats. The study used a preclinical animal experiment.
What Effects Did Molecular Hydrogen Have?
Source-reported hydrogen concentration: 0.6 mM H₂ (≈1.21 mg/L). At 30 and 90 min, no significant difference among the experimental groups in the MAP or HR was observed, suggesting that the hydrogen-rich water had no marked influence on the resuscitation of the blood pressure and HR, regardless of whether it was injected IV or IP. The authors concluded that in conclusion, itravenous injection of hydrogen-rich water is more effective than intraperitonal injection. Hydrogen is considered to be a novel antioxidant as it inhibits inflammation, removes oxygen-derived free radicals and reduces oxidative damage. hydrogen-rich water has anti-inflammatory and anti-oxidative effects in UHS.
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was rats. The study used a preclinical animal experiment. The hydrogen delivery method was hydrogen-rich water. The source-reported hydrogen concentration was 0.6 mM H₂ (≈1.21 mg/L).
Limitations and Safety
No separate limitations or safety findings were identified in the source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.